Search research articles
Contact Us
Filters
Showing results (91-100 of 230) with videos related to
Page
of 23
Sort By:
BMC Cancer
|
May 28, 2021
Genetic alteration of Chinese patients with rectal mucosal melanoma
Huan Li, Lujing Yang, Yumei Lai, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
February 11, 2014
[Expression and prognostic significance of galectin-1 and galectin-3 in benign nevi and melanomas]
Zhong-wu Li, Yan Wang, Wei-cheng Xue, et al.
Frontiers in Immunology
|
July 18, 2022
<i>CCND1</i> Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment
Jun Liu, Jing Lin, Xuefeng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2022
Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study
Lili Mao, Meiyu Fang, Yu Chen, et al.
BMC Cancer
|
November 11, 2024
MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study
Xiaojun Cai, Jing Lin, Caili Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors
Yan Kong, Lu Si, Yiqian Li, et al.
Annals of Surgical Oncology
|
December 23, 2017
Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China
Siming Li, Xinan Sheng, Lu Si, et al.
International Immunopharmacology
|
January 8, 2026
Corrigendum to "Obacunone inhibits RIPK1/RIPK3/MLKL-mediated necroptosis by suppressing mitochondrial ROS and MIF signaling in intestinal ischemia-reperfusion injury" [Int. Immunopharmacol. 168 (2026) 115901]
Xiao-Yao Li, Jing-Yuan Xie, Yu-Tong Yin, et al.
International Immunopharmacology
|
November 29, 2025
Obacunone inhibits RIPK1/RIPK3/MLKL-mediated necroptosis by suppressing mitochondrial ROS and MIF signaling in intestinal ischemia-reperfusion injury
Xiao-Yao Li, Jing-Yuan Xie, Yu-Tong Yin, et al.
Journal of Cancer
|
July 27, 2023
Prognostic Value of Lymph Node Necrosis at Different N Stages in Patients with Nasopharyngeal Carcinoma
Yue-Chun Fu, Shao-Bo Liang, Wen-Jie Huang, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 230) with videos related to
Sort By:
Page
of 23
BMC Cancer
|
May 28, 2021
Genetic alteration of Chinese patients with rectal mucosal melanoma
Huan Li, Lujing Yang, Yumei Lai, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
February 11, 2014
[Expression and prognostic significance of galectin-1 and galectin-3 in benign nevi and melanomas]
Zhong-wu Li, Yan Wang, Wei-cheng Xue, et al.
Frontiers in Immunology
|
July 18, 2022
<i>CCND1</i> Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment
Jun Liu, Jing Lin, Xuefeng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2022
Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study
Lili Mao, Meiyu Fang, Yu Chen, et al.
BMC Cancer
|
November 11, 2024
MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study
Xiaojun Cai, Jing Lin, Caili Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors
Yan Kong, Lu Si, Yiqian Li, et al.
Annals of Surgical Oncology
|
December 23, 2017
Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China
Siming Li, Xinan Sheng, Lu Si, et al.
International Immunopharmacology
|
January 8, 2026
Corrigendum to "Obacunone inhibits RIPK1/RIPK3/MLKL-mediated necroptosis by suppressing mitochondrial ROS and MIF signaling in intestinal ischemia-reperfusion injury" [Int. Immunopharmacol. 168 (2026) 115901]
Xiao-Yao Li, Jing-Yuan Xie, Yu-Tong Yin, et al.
International Immunopharmacology
|
November 29, 2025
Obacunone inhibits RIPK1/RIPK3/MLKL-mediated necroptosis by suppressing mitochondrial ROS and MIF signaling in intestinal ischemia-reperfusion injury
Xiao-Yao Li, Jing-Yuan Xie, Yu-Tong Yin, et al.
Journal of Cancer
|
July 27, 2023
Prognostic Value of Lymph Node Necrosis at Different N Stages in Patients with Nasopharyngeal Carcinoma
Yue-Chun Fu, Shao-Bo Liang, Wen-Jie Huang, et al.
Page
of 23